Call for papers: Advances in Cancer Immunotherapy
We are pleased to announce that Journal of Experimental & Clinical Cancer Research has launched a new thematic series on “Advances in Cancer Immunotherapy” to help summarize recent highlights in this field. Click here for further details on the series and for submission information.
Submission deadline: 31st May 2019
Click here to access all thematic series published to date in the Journal of Experimental & Clinical Cancer Research.
Featured article: The expansion of targetable biomarkers for CAR T cell therapy
Biomarkers are an integral part of cancer management due to their use in risk assessment, screening, differential diagnosis, prognosis, prediction of response to treatment, and monitoring progress of disease. In this review, Michelle Townsend et al. discuss the biomarkers currently under investigation and point out several promising biomarkers in the preclinical stage of development that may be useful as targets.
Click here to access the full article.
Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.